Stocks and Investing Stocks and Investing
Wed, June 7, 2023

Ed Arce Maintained (AKRO) at Strong Buy with Increased Target to $64 on, Jun 7th, 2023


Published on 2024-10-28 04:14:27 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Increased Target from $62 to $64 on, Jun 7th, 2023.

Ed has made no other calls on AKRO in the last 4 months.



There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $59 on, Wednesday, May 17th, 2023
Contributing Sources